LOGIN  |  REGISTER
Assertio
Recursion

Cigna Publishes 2023 ESG Report, Furthering Its Commitment to Advancing Better Health for All

July 09, 2024 | Last Trade: US$312.32 0.57 -0.18
  • Report highlights progress in each of the four pillars underpinning The Cigna Group's ESG framework: Healthy Society, Healthy Workforce, Healthy Environment, and Healthy Company

BLOOMFIELD, Conn., July 9, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) released its 2023 environmental, social, and governance (ESG) report, detailing the organization's ongoing efforts to strengthen communities and drive improvement to a more sustainable and equitable health care system.

"The Cigna Group is a purpose-built, high-performance organization dedicated to creating positive change around the world," said Geneva Brown, vice president, ESG and diversity, equity and inclusion, The Cigna Group. "We are committed to advancing our efforts to realize the vision we have for a better future built on the vitality of every individual and every community."

The Cigna Group's multi-dimensional ESG framework is based on four key pillars: Healthy Society, Healthy Workforce, Healthy Environment, and Healthy Company. The report includes key performance indicators, reporting, and recognitions. Learn more about the company's ESG efforts here.

About The Cigna Group

The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services, or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions and has more than 187 million customer relationships around the world. Learn more at thecignagroup.com.  

Media Contact
Madeline Ziomek
(202) 615-1473
This email address is being protected from spambots. You need JavaScript enabled to view it.

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB